Demonstrates anti-inflammatory effects of a polysaccharide in macrophages, implying potential therapeutic properties.
A bioactive polysaccharide (CDP-D1) was isolated from the bulbs of Cistanche deserticola and purified by DEAE anion-exchange chromatography, yielding a purity of 95.5% and a recovery rate of 33.1%. It exhibits an irregular amorphous structure, with a porous and loose surface, and displays distinct shear-thinning behavior. Its molecular weight (MW) is 142.52 kDa, and its polydispersity index (Mw/Mn) is 1.77, confirming its heterogeneity. Gas chromatography–mass spectrometry (GC-MS) and nuclear magnetic resonance (NMR) analysis identified it as a heteropolysaccharide. Functional studies indicate that CDP-D1 mediates a protective effect against lipopolysaccharide (LPS)-induced inflammation in RAW264.7 macrophages. CDP-D1 restored LPS-induced decreases in cell viability to near-normal levels and suppressed pro-inflammatory signaling by downregulating TLR4 mRNA, key cytokines (IL-1, IL-6, TNF-α), and their cascade amplification. Metabolomic analysis (PLS-DA) validated the reliability of the model and identified 420 metabolites. LPS induced metabolic suppression, whereas CDP-D1 reversed this trend. Key pathways regulated by CDP-D1 include glutathione metabolism and amino acid/nucleoside/purine metabolism, partially restoring metabolic homeostasis. These findings provide preliminary evidence that CDP-D1 modulates inflammatory responses in LPS-stimulated macrophages, potentially through regulation of oxidative stress and metabolic reprogramming, and warrant further investigation into its molecular mechanism of action.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: